Profile
Douglas Greene served as the Executive Vice President of Research and Development at Ikaria, Inc. He also worked as the Chief Medical Officer at Sanofi-Aventis Pharmaceuticals for a brief period in 2009.
Former positions of Douglas Greene
Companies | Position | End |
---|---|---|
Sanofi-Aventis Pharmaceuticals | Chief Tech/Sci/R&D Officer | 31/12/2008 |
IKARIA, INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Ikaria, Inc.
Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Sanofi-Aventis Pharmaceuticals |
- Stock Market
- Insiders
- Douglas Greene